WHO ICTRP trial
Umbilical cord blood transplantation in high-risk hematological patients using…
EUCTR2016-002383-13-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2016-002383-13-NL |
|---|---|
| Public title | Umbilical cord blood transplantation in high-risk hematological patients using stemregenin-1 expanded hematopoietic stem cells. A feasibility study focussing on engraftment and hematopoietic recovery. |
| Scientific title | Umbilical cord blood transplantation in high-risk hematological patients using stemregenin-1 expanded hematopoietic stem cells. A feasibility study focussing on engraftment and hematopoietic recovery. - Cord Blood Expansion (SR-1) |
| Primary sponsor | Erasmus MC |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Netherlands |
| Conditions | Patients with high-risk hematological diseases, who need a allogeneic stem cell transplantation but who lack a matched unrelated donor MedDRA version: 19.0 Level: PT Classification code 10061187 Term: Haematopoietic neoplasm System Organ… |
| Interventions | Product Name: Ex vivo-expanded umbilical cord blood-derived hematopoietic stem and progenitor cells Pharmaceutical Form: Solution for infusion in administration system INN or Proposed INN: Expanded UCB-derived HSPCs Current Sponsor code… |
| Registration date | Dec 9, 2016 |
| Secondary IDs | Cord_Blood_Expansion_(SR-1) |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: